CoChat

Quantity and Reporting Quality of Kidney Research

Open access
Chatzimanouil, Markos Kyriakos Tomidis, Wilkens, Louise, Anders, Hans-Joachim · 2019 · Journal of the American Society of Nephrology
Cited by 60

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Background: In 2004, researchers reported that the number of nephrology clinical trials was low and that the reporting quality of such trials was suboptimal. Furthermore, the number or quality of preclinical kidney-related studies has not been systematically evaluated. Methods: We performed a systematic review of randomized clinical trials published in 1966–2017 (listed in the Cochrane Library) and preclinical studies published in 1945–2017 (listed in PubMed). For reporting quality analysis, we evaluated the final main paper of 118 clinical trial reports and 135 preclinical studies published in leading journals in 1996, 2006, and 2016 on the basis of criteria from the widely used CONSORT and ARRIVE guidelines. Results: The annual number of reports of clinical kidney-related trials more than doubled between 2004 and 2014 along with reports in other medical disciplines. Hypertension remains the dominant focus of study, but ongoing trials also center on CKD, ESRD, and AKI. The reporting quality analysis revealed improvements, but deficits in reporting of clinical trial design, mode of randomization, and intention-to-treat analysis remain. Annual numbers of kidney-related preclinical studies remained low between 1945 and 2017 compared with other disciplines. Reporting quality analysis of preclinical studies revealed substantial reporting deficits across all leading journals, with little improvement over the last 20 years, especially for group size calculations, defining primary versus secondary outcomes, and blinded analysis. Conclusions: Nephrology studies keep increasing in number but still lag behind other medical disciplines, and the quality of data reporting in kidney research can be further improved.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1681/asn.2018050515

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 6

  1. Strippoli, 2004, The number, quality, and coverage of randomized controlled trials in nephrology, J Am Soc Nephrol, 15, 411, 10.1097/01.ASN.0000100125.21491.46 · DOI · Paper page
  2. Deo, 2011, Loss to analysis in randomized controlled trials in CKD, Am J Kidney Dis, 58, 349, 10.1053/j.ajkd.2011.04.023 · DOI
  3. Braybrook, 2017, Reproducibility: Developing standard measures for biology, Nature, 551, 168, 10.1038/d41586-017-05780-5 · doi:10.1038/d41586-017-05780-5
  4. Hsieh, 2018, Enhancing scientific foundations to ensure reproducibility: A new paradigm, Am J Pathol, 188, 6, 10.1016/j.ajpath.2017.08.028 · DOI
  5. Anders, 2016, Hurdles to the introduction of new therapies for immune-mediated kidney diseases, Nat Rev Nephrol, 12, 205, 10.1038/nrneph.2015.206 · DOI
  6. Miller, 2017, Considering sex as a biological variable in preclinical research, FASEB J, 31, 29, 10.1096/fj.201600781r · DOI · Paper page

Cited by

See all 60

Metadata

Authors
Chatzimanouil, M. K. T., Wilkens, L., & Anders, H.-J.
Venue
Journal of the American Society of Nephrology
Published
2018-12-13
Volume
30
Issue
1
Pages
13-22
ISSN
  • 1046-6673 (ISSN-L)
  • 1533-3450
OpenAlex
W2904077247
Cited by
60
References
8
FWCI
5.73
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Quantity and Reporting Quality of Kidney Research. https://app.cochat.ai/papers/10.1681/asn.2018050515
The paper
Chatzimanouil, M. K. T., Wilkens, L., & Anders, H.-J. (2019). Quantity and Reporting Quality of Kidney Research. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.2018050515

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.